Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 201–300 of 777
Lai, K. P., Ng, A. H.-M., Wan, H. T., Wong, A. Y.-M., Leung, C. C. T., Li, R., & Wong, C. K. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02552 · Cited by 98
Holtmann, G., & Talley, N. J. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.10.001 · Cited by 107
Li, Y., Su, X., Gao, Y., Lv, C., Gao, Z., Liu, Y., Wang, Y., Li, S., & Wang, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165764 · Cited by 102
The gut microbiome and hypertension
Pevsner‐Fischer, M., Blacher, E., Tatirovsky, E., Ben‐Dov, I. Z., & Elinav, E. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000293 · Cited by 93
Atkinson, M. A., & Chervonsky, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2672-4 · Cited by 91
“More recent studies from this same group switched techniques from 16S to metagenomic analysis, efforts that represent movement from a species-based approach towards one of function [85].”
BackgroundSelf-citationHu, T., Wen, P., Shen, W., Liu, F., Li, Q., Erna, L., Liao, S., Wu, H., & Zou, Y. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00205 · Cited by 92
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications
Bai, G.-H., Lin, S., Hsu, Y., & Chen, S.-Y. (2022) · Viruses · doi:10.3390/v14020278 · Cited by 100
Gut Microbiota and Type 1 Diabetes
Vaarala, O. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.251 · Cited by 103
“Brown and co-authors reported that mucindegrading bacteria of the genera Prevotella and Akkermansia were 20- and 140- fold higher in the four control children compared with the four diabetic children [31].”
BackgroundResultInfluentialThe Role of Epigenetics in Type 1 Diabetes
Jerram, S. T., Dang, M. N., & Leslie, R. D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0916-x · Cited by 84
Mokhtari, P., Metos, J., & Babu, P. V. A. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1926841 · Cited by 98
“A limited number of studies conducted the metagenomic analysis to map the differences in the functional potential of gut microbiome between individuals with T1D and healthy individuals.(23,44,47,48,59,60,73) These studies reported the impact of T1D on the alteration in metabolic pathways.”
BackgroundResultInfluentialOgrotis, I., Koufakis, T., & Kotsa, K. (2023) · Medicina · doi:10.3390/medicina59040668 · Cited by 111
Consumption of Acidic Water Alters the Gut Microbiome and Decreases the Risk of Diabetes in NOD Mice
Wolf, K. J., Daft, J. G., Tanner, S. M., Hartmann, R., Khafipour, E., & Lorenz, R. G. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413519650 · Cited by 76
“The shifts observed in the microbiome of pre-diabetic NOD-N mice were similar to previously described shifts in diabetic patients (Brown et al. 2011).”
BackgroundHu, Y., Peng, J., Tai, N., Hu, C., Zhang, X., Wong, F. S., & Li, W. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500884 · Cited by 87
Microbiome manipulation modifies sex-specific risk for autoimmunity
Markle, J. G., Frank, D. N., Adeli, K., von Bergen, M., & Danska, J. S. (2014) · Gut Microbes · doi:10.4161/gmic.29795 · Cited by 86
“Evidence of intestinal dysbiosis in autoimmune disease patients is beginning to emerge.(68,69) Studies in rodent models of T1D(70,71) including our recent study,(1) suggest that intestinal commensal bacteria are important determinants of disease progression.”
BackgroundLinking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?
Scheperjans, F., Pekkonen, E., Kaakkola, S., & Auvinen, P. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150557 · Cited by 83
“impairment of mucin synthesis and barrier function [43, 44].”
BackgroundHuman Intestinal Microbiota and Type 1 Diabetes
Vaarala, O. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0409-5 · Cited by 95
The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis
Simões‐Silva, L., Araújo, R., Pestana, M., Soares‐Silva, I., & Sampaio‐Maia, B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.011 · Cited by 93
Impact of the gut microbiota on rodent models of human disease
Hansen, A. K., Hansen, C. H. F., Krych, Ł., & Nielsen, D. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17727 · Cited by 87
Host-Microbiota Interactions in the Pathogenesis of Antibiotic-Associated Diseases
Lichtman, J. S., Ferreyra, J. A., Ng, K. M., Smits, S. A., Sonnenburg, J. L., & Elias, J. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.009 · Cited by 83
“, 2015) and diabetic patients (Brown et al., 2011; de Goffau et al., 2013) demonstrated altered pancreatic output in response to lower levels of butyrate-producing microbes.”
BackgroundMichels, A. W., Zhang, L., Khadra, A., Kushner, J. A., REDONDO, M. J., & Pietropaolo, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12299 · Cited by 94
“Several studies have reported examples of dysbiosis in patients with T1DM (45, 46), but the cause–effect relationship between dysbiosis, metabolic disorder and/or infection is unclear.”
BackgroundMartemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
“In addition, it is characterised by an increased Bacteroidetes – Firmicutes ratio [287]; large amounts of Blautia spp., Streptococcus spp. and Rikenellaceae ; and low levels of Lactobacillus , Bifidobacterium , Blautia coccoides , Faecalibacterium spp. and bacteria that degrade mucin as Akkermansia…”
InfluentialPatterson, E., Marques, T. M., O’Sullivan, O., Fitzgerald, P., Fitzgerald, G. F., Cotter, P. D., Dinan, T. G., Cryan, J. F., Stanton, C., & Ross, R. P. (2015) · Microbiology · doi:10.1099/mic.0.082610-0 · Cited by 83
MiMeNet: Exploring microbiome-metabolome relationships using neural networks
Reiman, D., Layden, B. T., & Dai, Y. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009021 · Cited by 80
Gargari, G., Taverniti, V., Balzaretti, S., Ferrario, C., Gardana, C., Simonetti, P., & Guglielmetti, S. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01753-16 · Cited by 79
Half-lives of PAHs and temporal microbiota changes in commonly used urban landscaping materials
Roslund, M. I., Grönroos, M., Rantalainen, A., Jumpponen, A., Romantschuk, M., Parajuli, A., Hyöty, H., Laitinen, O. H., & Sinkkonen, A. (2018) · PeerJ · doi:10.7717/peerj.4508 · Cited by 87
“, immune modulation and metabolism (Bradley & Pollard, 2017), and reduced bacterial functional diversity in the gut microbiome increases the risk of type 1 diabetes (Brown et al., 2011).”
BackgroundSelf-citationBeyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes
Nielsen, D. S., Krych, Ł., Buschard, K., Hansen, C. H. F., & Hansen, A. K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.010 · Cited by 75
“increased mucin production then creates a favorable niche for mucin degraders (Prevotella, Akkermansia), and [118] suggest that”
Diabetic cats have decreased gut microbial diversity and a lack of butyrate producing bacteria
Kieler, I. N., Osto, M., Hugentobler, L., Puetz, L., Gilbert, M. T. P., Hansen, T. F., Pedersen, O. B., Reusch, C. E., Zini, E., Lutz, T. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41195-0 · Cited by 88
Differences in microbial signatures between rectal mucosal biopsies and rectal swabs
Araújo-Pérez, F., McCoy, A. N., Okechukwu, C., Carroll, I. M., Smith, K. M., Jeremiah, K., Sandler, R. S., Asher, G. N., & Keku, T. O. (2012) · Gut Microbes · doi:10.4161/gmic.22157 · Cited by 76
“Increasing evidence suggests a role for the intestinal microbiota in colorectal cancer (CRC),(1) colorectal adenomas(2) and several other conditions such as inflammatory bowel diseases (ulcerative colitis and Crohn disease),(3) irritable bowel syndrome (IBS),(4) obesity(5) and type-1 diabetes.(6) The launch of the Hum…”
BackgroundTurna, J., Grosman Kaplan, K., Anglin, R., & Van Ameringen, M. (2016) · Depression and Anxiety · doi:10.1002/da.22454 · Cited by 73
“[9] Changes in the gut microbiome have been observed in a number of illnesses such as inflammatory bowel disease,[5] autism,[10] celiac disease,[11] diabetes,[12] and obesity.”
BackgroundCui, H.-X., Hu, Y.-N., Li, J.-W., & Yuan, K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8930374 · Cited by 74
Higuchi, B. S., Rodrigues, N. D. C., Gonzaga, M. I., Paiolo, J. C. C., Stefanutto, N. A. V., Omori, W. P., Pinheiro, D. G., Brisotti, J. L., Matheucci, E., Mariano, V. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01689 · Cited by 81
“Previous reports showed that T1D children with autoantibo dies have an increase in the Gramnegative Bacteroidetes members, reduction in mucindegradation and butyrateproducing species (10, 35, 36).”
BackgroundGut Microbiota in Neurological Disorders
Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 84
Zou, S., Zhang, J., & Zhang, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184394 · Cited by 76
Slattery, J., Macfabe, D. F., & Frye, R. E. (2016) · Clinical Medicine Insights: Pediatrics · doi:10.4137/cmped.s38338 · Cited by 71
Gao, M., Wang, H., Luo, H., Sun, Y., Wang, L., Ding, S., Ren, H., Gang, J., Rao, B., Liu, S., et al. (2021) · Advanced Science · doi:10.1002/advs.202102785 · Cited by 81
Metabolomics – a novel window into inflammatory disease
Fitzpatrick, M. A., & Young, S. P. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13743 · Cited by 87
Diabetes-related alterations in the enteric nervous system and its microenvironment
Bagyánszki, M. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i5.80 · Cited by 71
Approaches and advances in the genetic causes of autoimmune disease and their implications
Inshaw, J. R. J., Cutler, A. J., Burren, O. S., Stefana, M. I., & Todd, J. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0129-8 · Cited by 70
Jacob, N., Jaiswal, S., Maheshwari, D., Nallabelli, N., Khatri, N., Bhatia, A., Bal, A., Malik, V. S., Verma, S., Kumar, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76109-y · Cited by 76
Kunath, B. J., Hickl, O., Queirós, P., Martin‐Gallausiaux, C., Lebrun, L., Halder, R., Laczny, C. C., Schmidt, T., Hayward, M. R., Becher, D., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01435-4 · Cited by 72
“Several studies have shown alterations of the gut micro-biome composition between individuals with T1DM compared to healthy controls [29–32].”
BackgroundEpithelial Barrier Function in Gut-Bone Signaling
Rios‐Arce, N. D., Collins, F. L., Schepper, J. D., Steury, M. D., Raehtz, S., Mallin, H., Schoenherr, D. T., Parameswaran, N., & McCabe, L. R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66653-2_8 · Cited by 80
Functional profiling of the gut microbiome in disease-associated inflammation
Börnigen, D., Morgan, X. C., Franzosa, E. A., Ren, B., Xavier, R. J., Garrett, W. S., & Huttenhower, C. (2013) · Genome Medicine · doi:10.1186/gm469 · Cited by 67
“As a T-cell-mediated metabolic disease, type 1 diabetes is another prime candidate for involvement of the gut microbiota [5,10,91].”
BackgroundPaun, A., & Danska, J. S. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12424 · Cited by 67
Marques, T. M., Cryan, J. F., Shanahan, F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2013) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2013.10.016 · Cited by 74
“Altered gut microbiota composition is also associated with premature infancy and such medical conditions as obesity (Tremaroli & Backhed, 2012), diabetes (Brown et al., 2011), atherosclerosis (Koren et al.”
BackgroundGut microbiota and gestational Diabetes Mellitus: A systematic review
Dualib, P. M., Ogassavara, J., Mattar, R., da Silva, E. M. K., Dib, S. A., & de Almeida-Pititto, B. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109078 · Cited by 73
The multiple origins of Type 1 diabetes
Pugliese, A. (2013) · Diabetic Medicine · doi:10.1111/dme.12081 · Cited by 81
Microbiota, Immune Subversion, and Chronic Inflammation
Kramer, C. D., & Genco, C. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00255 · Cited by 71
Gut dysbiosis and multiple sclerosis
Noto, D., & Miyake, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108380 · Cited by 65
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Biernacki, T., Sandi, D., Bencsik, K., & Vécsei, L. (2020) · Cells · doi:10.3390/cells9061564 · Cited by 71
Chen, L., Wang, Z., Wang, P., Yu, X., Ding, H., Wang, Z., & Feng, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00483-21 · Cited by 69
Heravi, F. S. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00213-6 · Cited by 79
Huang, G., Xu, J., Lefever, D. E., Glenn, T. C., Nagy, T., & Guo, T. L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.04.009 · Cited by 70
“2C), suggesting a protection against T1D (Brown et al., 2011; Qi et al., 2016; Murri et al., 2013).”
Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes
Kondrashova, A., & Hyöty, H. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.889130 · Cited by 76
“Another study showed that healthy children had a higher proportion of butyrate-producing and mucin-degrading bacteria compared to cases, while non-butyrate-producing lactateutilizing bacteria were more prevalent in cases [22].”
ResultSelf-citationCurrent understanding of the role of gut dysbiosis in type 1 diabetes
Abdellatif, A. M., & Sarvetnick, N. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12915 · Cited by 75
“A decreased diversity of the gut microbiome was reported in children with β-cell autoimmunity and in those who progressed to clinical T1D compared with non-seroconverted controls.(50,54) Kostic et al.”
ResultMou, J., Li, Q., Shi, W., Qi, X., Song, W., & Yang, J. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115359 · Cited by 69
In Vitro Digestion and Fermentation by Human Fecal Microbiota of Polysaccharides from Flaxseed
Zhou, X., Zhang, Z., Huang, F., Yang, C., & Huang, Q. (2020) · Molecules · doi:10.3390/molecules25194354 · Cited by 65
“SCFAs can not only modulate immune response to prevent colorectal cancer, but also regulate the characteristics of metabolic syndrome [13,14].”
BackgroundBlood-based signatures in type 1 diabetes
Cabrera, S. M., Chen, Y.-G., Hagopian, W., & Hessner, M. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3843-x · Cited by 65
“Beta cell autoimmunity has been associated with changes including reduced microbial diversity and a reduction in the bacterial phylum Firmicutes relative to Bacteroidetes [42, 44].”
Ejtahed, H., Tavassol, Z. H., Khatami, S., Zangeneh, M., Behrouzi, A., Badi, S. A., Moshiri, A., Hasani‐Ranjbar, S., Soroush, A., Vaziri, F., et al. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00502-7 · Cited by 70
Immune recognition and response to the intestinal microbiome in type 1 diabetes
Paun, A., Yau, C., & Danska, J. S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.004 · Cited by 76
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
Czaja, A. J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9257 · Cited by 64
Park, M. J., Pilla, R., Panta, A., Pandey, S., Sarawichitr, B., Suchodolski, J. S., & Sohrabji, F. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00760-5 · Cited by 68
Moshkelgosha, S., Masetti, G., Berchner‐Pfannschmidt, U., Verhasselt, H. L., Horstmann, M., Díaz‐Cano, S. J., Noble, A., Edelman, B., Covelli, D., Plummer, S. F., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0653-3766 · Cited by 64
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review
Sawicka‐Gutaj, N., Gruszczyński, D., Zawalna, N., Nijakowski, K., Muller, I., Karpiński, T. M. M., Salvi, M., & Ruchała, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113450 · Cited by 72
“Furthermore, this leads to the disruption of gut homeostasis and may be involved in the pathogenesis and exacerbation of autoimmune disorders [66].”
BackgroundGut Microbial Metabolites on Host Immune Responses in Health and Disease
Yoon, J.-H., Do, J.-S., Velankanni, P., Lee, C., & Kwon, H. (2023) · Immune Network · doi:10.4110/in.2023.23.e6 · Cited by 71
“Decreased in IBD patients (127,128) Decreased in type 1 diabetes patients (162) Decreased in allergic infants (163) BA Primary CA FXR, GGPBAR1, chimeric antigen receptor Relatively increased in IBD, accelerate LN metastasis of tumor (taurine conjugated) (138,164)”
BackgroundGroele, L., Szajewska, H., & Szypowska, A. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017178 · Cited by 71
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 56
“The reduction in the number of Prevotellaceae diminishes the levels of beneficial neuroactive SCFAs and decrease the biosynthesis of thiamine and folate, thus suggesting a cause of the lack of these vitamins in PD patients [86,87].”
BackgroundRegulatory Role of Natural Killer T Cells in Diabetes
Tard, C., Rouxel, O., & Lehuen, A. (2015) · Biomedical Journal · doi:10.1016/j.bj.2015.04.001 · Cited by 65
“Conversely, a recent study performed in mice revealed that sphingolipids produced by a symbiotic microbe, Bacteroides fragilis , inhibit the proliferation of iNKT cells in the gut of newborns and limit their local accumulation [72].”
BackgroundThe Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis
Needell, J. C., & Zipris, D. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0781-z · Cited by 66
Zouiouich, S., Loftfield, E., Huybrechts, I., Viallon, V., Louca, P., Vogtmann, E., Wells, P. M., Steves, C. J., Herzig, K., Menni, C., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05464-w · Cited by 70
The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue
Hagihara, M., Yamashita, R., Matsumoto, A., Mori, T., Kuroki, Y., Kudo, H., Oka, K., Takahashi, M., Nonogaki, T., Yamagishi, Y., et al. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.07.012 · Cited by 60
Zhou, H., Zhao, X. Y., Sun, L., Liu, Y., Lv, Y., Gang, X., & Wang, G. (2020) · Disease Markers · doi:10.1155/2020/3936247 · Cited by 66
Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet
Calabrese, C. M., Valentini, A., & Calabrese, G. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.612773 · Cited by 58
“The large amount of Bacterioides contributes to the production of SCFAs other than butyrate (49), leading to a higher gut permeability (50) and thus contributing to the development of anti-islet cell autoantibodies (34, 51).”
BackgroundMarques, T. M., Patterson, E., Wall, R., O’Sullivan, O., Fitzgerald, G. F., Cotter, P. D., Dinan, T. G., Cryan, J. F., Ross, R. P., & Stanton, C. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0154 · Cited by 60
Cinek, O., Kramná, L., Lin, J., Oikarinen, S., Kolářová, K., Ilonen, J., Simell, O., Veijola, R., Autio, R., & Hyöty, H. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12468 · Cited by 61
“The first studies on the human intestinal microbiome and T1D or islet autoimmunity were published in 2011, with 4 cases and 4 controls.(3,4) Further 2 important studies were published in 2013, larger in size, but with methods prone to considerable biases.”
BackgroundSelf-citationGut microbiota in pancreatic diseases: possible new therapeutic strategies
Pan, L., Li, B., Pan, X., & Sun, J. T. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00532-0 · Cited by 65
Stefanaki, C., Peppa, Μ., Mastorakos, G. P., & Chrousos, G. P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.014 · Cited by 58
“This finding may directly implicate the gut microbiome in T1D onset, and may indicate the establishment of inflammation, and autoimmunity in the gut [40, 106].”
BackgroundPaun, A., Yau, C., Meshkibaf, S., Daigneault, M. C., Marandi, L., Mortin-Toth, S. M., Bar‐Or, A., Allen‐Vercoe, E., Poussier, P., & Danska, J. S. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau8125 · Cited by 64
The Effects of Stress and Meditation on the Immune System, Human Microbiota, and Epigenetics.
Househam, A. M., Peterson, C. T., Mills, P. J., & Chopra, D. (2017) · PubMed · Cited by 96
Revisiting the Bacterial Phylum Composition in Metabolic Diseases Focused on Host Energy Metabolism
Lee, Y., & Lee, H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0220 · Cited by 59
“The ratio of Firmicutes to Bacteroidetes is decreased in NAFLD patients [10,30,31], in type 1 and the type 2 diabetes mellitus [32,33].”
BackgroundThompson, K. N., Bonham, K. S., Ilott, N. E., Britton, G. J., Colmenero, P., Bullers, S. J., McIver, L. J., Ma, S., Nguyen, L. H., Filer, A. D., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4722 · Cited by 59
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes
Radwan, S., Gilfillan, D., Eklund, B., Radwan, H. M., Menofy, N. G. E., Lee, J., Kapuscinski, M. L., & Abdo, Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238764 · Cited by 61
“High incidence of this disease can also be attributed to environmental factors [17].”
Ye, J., Wu, Z., Zhao, Y., Zhang, S., Liu, W.-T., & Su, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1029890 · Cited by 65
“Prebiotics are non-digestible dietary components that promote the host’s health by regulating the gut microbiota composition, especially by augmenting the abundance of Bifidobacteria and/ or Lactobacillus (Jakaitis and Denning, 2014).”
BackgroundResultInfluentialBrown, C. T., Sharon, I., Thomas, B. C., Castelle, C. J., Morowitz, M. J., & Banfield, J. F. (2013) · Microbiome · doi:10.1186/2049-2618-1-30 · Cited by 58
“Aberrations in gut microbiota membership and community structure, termed microbial dysbiosis, have been associated with obesity [8] and diseases such as inflammatory bowel disease [9], both type 1 and type 2 diabetes [10,11], and necrotizing enterocolitis in premature infants [12-14].”
Self-citationStewart, C. J., Nelson, A., Campbell, M. D., Walker, M., Stevenson, E. J., Shaw, J. A., Cummings, S. P., & West, D. J. (2017) · Diabetic Medicine · doi:10.1111/dme.13140 · Cited by 55
“Previous studies have suggested an increase of butyrate-producing and mucin-degrading 194 bacteria in controls, whereas bacteria that produce short chain fatty acids (SCFAs) other than 195 butyrate were higher in disease cases [21].”
Gülden, E., Chao, C., Tai, N., Pearson, J. A., Peng, J., Majewska‐Szczepanik, M., Zhou, Z., Wong, F. S., & Li, W. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.06.003 · Cited by 60
“The changes include a reduction of diversity in the composition of gut microbiota but an increased relative abundance of some gut bacterial species in patients with T1D compared to healthy individuals [28,[31], [32], [33], [34]] .”
BackgroundInonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice
Hu, Y., Teng, C., Yu, S., Wang, X., Liang, J., Bai, X., Dong, L., Song, T., Yu, M., & Qu, J. (2017) · AMB Express · doi:10.1186/s13568-017-0341-1 · Cited by 60
“The production of SCFA can provide energy for microbes, modulating immune responses and maintaining the epithelial barrier function (Brown et al. 2011).”
BackgroundRole of the intestinal microbiome in autoimmune diseases and its use in treatments
Marietta, E. V., Horwath, I. E., Balakrishnan, B., & Taneja, V. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.005 · Cited by 59
Type 1 diabetes and gut microbiota: Friend or foe?
Hu, C., Wong, F. S., & Li, W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.006 · Cited by 63
Cabello-Olmo, M., Oneca, M., Torre, P., Sáinź, N., Moreno-Aliaga, M. J., Guruceaga, E., Cano, J. V. D., Encío, I., Barajas, M. A., & Araña, M. (2019) · Nutrients · doi:10.3390/nu11102530 · Cited by 66
“On the contrary, previous works reported its enrichment in T1D [67] and T2D individuals [12].”
ResultInfluentialIntestinal microbiota changes in Graves’ disease: a prospective clinical study
Yan, H.-X., An, W.-C., Chen, F., An, B., Pan, Y., Jin, J., Xia, X., Cui, Z.-J., Jiang, L., Zhou, S.-J., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20191242 · Cited by 61
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Perez-Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 51
Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies
Leal‐Lopes, C., Velloso, F. J., Campopiano, J. C., Sogayar, M. C., & Correa, R. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/284680 · Cited by 58
“Prevotella genera Children positive to T1D autoimmune process More abundant in controls; synthetizing mucin [195]”
BackgroundInfluentialImplication of Gut Microbiota in Diabetes Mellitus and Obesity
Grigorescu, I., & Dumitrascu, D. L. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.206 · Cited by 57
“Another argument for the role of microbiota in T1DM etiology is the diminished amount of genus Faecalibacterium and Prevotella in diabetes patients, and the Bacteroides was somewhat less than 2-fold more common in diabetics than in control patients (40).”
BackgroundIs There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
Das, U. N. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00182 · Cited by 57
“Beysen C, Karpe F, Fielding BA, Clark A, Levy JC, Frayn KN. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.”
BackgroundInfluentialChanges of intestinal flora in patients with systemic lupus erythematosus in northeast China
Feng, W., Xu, H., Yan, C., Rong, C., Liu, B., & Zhou, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213063 · Cited by 53
Fernández-Edreira, D., Liñares-Blanco, J., & Fernandez-Lozano, C. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.115648 · Cited by 55
Why is the Incidence of Type 1 Diabetes Increasing?
Abela, A. G., & Fava, S. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210503133747 · Cited by 63
Rodrigues, N. F., Kästle, J., Coutinho, T. J. D., Amorim, A. T., Campos, G. B., Santos, V. M., Marques, L. M., Timenetsky, J., & de Farías, S. T. (2015) · Genetics and Molecular Research · doi:10.4238/2015.june.12.4 · Cited by 57
“…in ecology and referring to the microbial community of a particular environment (e.g., a specific location in the body of an individual), has contributed to the identification of microorganisms responsible for the balance of the health of the host (Turnbaugh and Gordon, 2009; Brown et al., 2011).”
BackgroundInfluence of Porphyromonas gingivalis in gut microbiota of streptozotocin‐induced diabetic mice
Ohtsu, A., Takeuchi, Y., Katagiri, S., Suda, W., Maekawa, S., Shiba, T., Komazaki, R., Udagawa, S., Sasaki, N., Hattori, M., et al. (2019) · Oral Diseases · doi:10.1111/odi.13044 · Cited by 58
Gut microbiota and metabolites in the pathogenesis of endocrine disease
Fenneman, A. C., Rampanelli, E., Yin, Y. S., Ames, J., Blaser, M. J., Fliers, E., & Nieuwdorp, M. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190686 · Cited by 62
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.